Beyond the stomach: An updated view ofHelicobacter pyloripathogenesis, diagnosis, and treatment

作者: Traci L Testerman , James Morris

DOI: 10.3748/WJG.V20.I36.12781

关键词:

摘要: Helicobacter pylori (H. pylori) is an extremely common, yet underappreciated, pathogen that able to alter host physiology and subvert the immune response, allowing it persist for life of host. H. primary cause peptic ulcers gastric cancer. In United States, annual cost associated with ulcer disease estimated be $6 billion cancer kills over 700000 people per year globally. The prevalence infection remains high (> 50%) in much world, although rates are dropping some developed nations. drop could a double-edged sword, reducing incidence diseases while increasing risk allergies esophageal diseases. list potentially caused by continues grow; however, mechanistic explanations how contribute extragastric lag far behind clinical studies. A number factors virulence act concert determine which individuals at highest disease. These include bacterial cytotoxins polymorphisms genes responsible directing response. This review discusses latest advances pathogenesis, diagnosis, treatment. Up-to-date information on correlations between also provided.

参考文章(318)
D. C. Haines, R. E. Benveniste, J. M. Ward, M. R. Anver, Chronic active hepatitis in mice caused by Helicobacter hepaticus American Journal of Pathology. ,vol. 145, pp. 959- 968 ,(1994)
Giuseppe Minniti, Maurizio Valeriani, Luigi Ruco, Massimo Marignani, Vitaliana De Sanctis, Riccardo Maurizi Enrici, Maria Christina Cox, Veronica Armosini, Stefano Angeletti, Daniela Assisi, Anti-Helicobacter pylori therapy in primary MALT lymphoma of rectum. Tumori. ,vol. 98, ,(2012) , 10.1700/1146.12654
Wolfgang Fischer, Sandra Prassl, Rainer Haas, Virulence Mechanisms and Persistence Strategies of the Human Gastric Pathogen Helicobacter pylori Current Topics in Microbiology and Immunology. ,vol. 337, pp. 129- 171 ,(2009) , 10.1007/978-3-642-01846-6_5
Bai X, Fan Z, Wang D, Zhang G, Xu L, Wang H, Li J, Han Y, Lu S, Liu W, Helicobacter pylori may cause otitis media with effusion: a pilot study. B-ent. ,vol. 8, pp. 261- ,(2012)
Xueming Wan, Sanping Xu, Yali Zhou, Minghu Cheng, Zhiqiang Song, Xiaolan Zheng, Xiaohua Hou, Yiqi Du, Symptom improvement after helicobacter pylori eradication in patients with functional dyspepsia-A multicenter, randomized, prospective cohort study. International Journal of Clinical and Experimental Medicine. ,vol. 6, pp. 747- 756 ,(2013)
Vesić S, Dukić S, Daković Z, Janković-Terzić K, Milenković S, Pavlović, Vuković J, Ocular rosacea and treatment of symptomatic Helicobacter pylori infection: a case series. Acta dermatovenerologica Alpina, Pannonica, et Adriatica. ,vol. 16, pp. 83- 86 ,(2007)
G Goerz, F Susanto, S Reinauer, H Reinauer, S Humfeld, T Ruzicka, HELICOBACTER PYLORI IN PATIENTS WITH SYSTEMIC SCLEROSIS : DETECTION WITH THE 13C-UREA BREATH TEST AND ERADICATION Acta Dermato-venereologica. ,vol. 74, pp. 361- 363 ,(1994) , 10.2340/0001555574361363
Doron Boltin, Yaron Niv, Ghrelin, Helicobacter pylori and body mass: is there an association? Israel Medical Association Journal. ,vol. 14, pp. 130- ,(2012)
Hilmi Ataseven, Mehmet Demir, Ramazan Gen, Effect of Sequential Treatment as a First-Line Therapy for Helicobacter pylori Eradication in Patients with Diabetes Mellitus Southern Medical Journal. ,vol. 103, pp. 988- 992 ,(2010) , 10.1097/SMJ.0B013E3181EEA6CC
Graham Dy, Bayerdörffer E, Miehlke S, Treatment of Helicobacter pylori infection. Seminars in gastrointestinal disease. ,vol. 12, pp. 167- 179 ,(2001)